WinRho SDF INJECTION		version 1/23/2025		

Appointment Requests 	

	
	Interval	Defer Until	Duration	
	☑	Referral to IV Infusion Room	Once	S	1 treatment	
		Status: Future, Expected: S, Expires: S+365, Clinic Performed
	Urgency of Scheduling: Routine		

Provider Communication 	

	
	Interval	Defer Until	Duration	
	☐	Provider communication	Once	S	1 treatment	
		Contraindicated in patients with IgA deficiency.		
	☐	Provider communication	Once	S	1 treatment	
		Patient must be Rh (+) and have a functioning spleen.		
	☐	Provider communication	Once	S	1 treatment	
		Decrease dose to 25-40 mcg/kg if Hgb < 10 gm/dL.		

Nursing Orders 	

	
	Interval	Defer Until	Duration	
	☐	Insert Peripheral IV or Access Portacath	Once	S	1 treatment	
		No details available for preview		
	☐	sodium chloride 0.9% flush 10 mL	Once	S	1 treatment	
		10 mL, intravenous, PRN, line care, Starting when released, for 10 doses		
	☐	sodium chloride 0.9% infusion 250 mL	Once	S	1 treatment	
		250 mL, intravenous, at 30 mL/hr, PRN, Flush bag, Starting when released, Until Discontinued		
	☐	Vital signs - T/P/R/BP Per Unit Protocol	Once	S	1 treatment	
		Observe patient for at least 20 minutes following administration.		
	☐	Nursing communication	Once	S	1 treatment	
		Call MD if patient experiences back pain, shaking, chills, edema, dyspnea, fever, or discolored urine.		
	☐	Nursing communication	Once	S	1 treatment	
		Tell patient to call MD after leaving if they experience any of the above symptoms within 4 hours of infusion.		
	☐	Nursing communication	Once	S	1 treatment	
		Please infuse at a rate of 2mL every 15 to 60 seconds.		

Medications 	

	
	Interval	Defer Until	Duration	
	☐	rho(D) immune globulin-maltose (WINRHO) 1,500 unit (300 mcg)/1.3 mL injection	Once	S	1 treatment	
		intravenous, once, Starting when released
	Please infuse at a rate of 2mL every 15 to 60 seconds.		

Discharge Nursing Orders 	

	
	Interval	Defer Until	Duration	
	☐	Discontinue IV	Once	S	1 treatment	
		No details available for preview